The basement membrane of intramyocardial capillaries is thickened in patients with acute myocardial infarction

Journal of Vascular Research

Volumn 47, Issue 1, 2009, Pages 54-60

  Begieneman, Mark P V ^a,b,c   Van De Goot, Frank R W ^a,b,c   Krijnen, Paul A J ^a,b   Fritz, Jan ^a   Paulus, Walter J ^a,b   Spreeuwenberg, Marieke D ^a   Van Hinsbergh, Victor W M ^a,b   Niessen, Hans W M ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c Dutch Forensic Institute   (Netherlands)

Author keywords

Acute myocardial infarction; Basement membrane; Blood vessel; Capillary; Coronary artery; Electron microscopy; Stenosis

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAPILLARY BASEMENT MEMBRANE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; FEMALE; HEART LEFT VENTRICLE; HEART MUSCLE CAPILLARY; HISTOPATHOLOGY; HUMAN; MALE; PRIORITY JOURNAL; THICKNESS;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTERIOR WALL MYOCARDIAL INFARCTION; AUTOPSY; BASEMENT MEMBRANE; CAPILLARIES; CASE-CONTROL STUDIES; CORONARY STENOSIS; CORONARY VESSELS; DISEASE MODELS, ANIMAL; FEMALE; HEART VENTRICLES; HUMANS; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; RATS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 68349113689     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000231721     Document Type: Article

References (37)

1. Murray CJ, Lopez AD: Alternative projections of mortality and disability by cause, 1990-2020: Global Burden of Disease Study. Lancet 1997; 349:1498-1504.
2. Murray CJ, Lopez AD: Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997; 349:1269-1276.
3. Theroux P, Fuster V: Acute coronary syndromes: unstable angina and non-Q-wave myocardial infarction. Circulation 1998; 97:1195-1206.
4. Myerburg RJ, Kessler KM, Castellanos A: Sudden cardiac death. Structure, function, and time-dependence of risk. Circulation 1992; 85(1 suppl): I2-I10.
5. Myerburg RJ, Kessler KM, Castellanos A: Sudden cardiac death: epidemiology, transient risk, and intervention assessment. Ann Intern Med 1993; 119:1187-1197.
6. Myerburg RJ, Interian A Jr, Mitrani RM, Kessler KM, Castellanos A: Frequency of sudden cardiac death and profiles of risk. Am J Cardiol 1997; 80:10F-19F.
7. Zipes DP, Wellens HJ: Sudden cardiac death. Circulation 1998; 98:2334-2351.
8. Califf RM, Pieper KS, Lee KL, Van de WF, Simes RJ, Armstrong PW, et al: Prediction of 1-year survival after thrombolysis for acute myocardial infarction in the global utilization of streptokinase and TPA for occluded coronary arteries trial. Circulation 2000; 101:2231-2238.
9. Gibson CM, Cannon CP, Piana RN, Breall JA, Sharaf B, Flatley M, et al: Angiographic predictors of reocclusion after thrombolysis: results from the Thrombolysis in Myocar-dial Infarction (TIMI) 4 trial. J Am Coll Cardiol 1995; 25:582-589.
10. Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ, et al: TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996; 93:879-888.
11. Gibson CM, Murphy S, Menown IB, Sequei-ra RF, Greene R, Van de Werf F, et al: Determinants of coronary blood flow after throm-bolytic administration. TIMI Study Group. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 1999; 34:1403-1412.
12. Gibson CM, Cannon CP, Murphy SA, Marble SJ, Barron HV, Braunwald E: Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction. Circulation 2002; 105:1909-1913.
13. Lee KL, Woodlief LH, Topol EJ, Weaver WD, Betriu A, Col J, et al: Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. Circulation 1995; 91:165 9-1668.
14. Lundergan CF, Reiner JS, McCarthy WF, Coyne KS, Califf RM, Ross AM: Clinical predictors of early infarct-related artery patency following thrombolytic therapy: importance of body weight, smoking history, infarct-re-lated artery and choice of thrombolytic regimen: the GUSTO-I experience. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries. J Am Coll Cardiol 1998; 32:641-647.
15. Baidoshvili A, Krijnen PA, Kupreishvili K, Ciurana C, Bleeker W, Nijmeijer R, et al: N(varepsilon)-(carboxymethyl)lysine depositions in intramyocardial blood vessels in human and rat acute myocardial infarction: a predictor or reflection of infarction? Arterioscler Thromb Vasc Biol 2006; 26:2497-2503.
16. Estep JD, Aguilar D: Diabetes and heart failure in the post-myocardial infarction patient. Curr Heart Fail Rep 2006; 3:164-169.
17. Pajunen P, Koukkunen H, Ketonen M, Jerk-kola T, Immonen-Raiha P, Karja-Koskenkari P, et al: Myocardial in farction in diabetic a nd non-diabetic persons with and without prior myocardial infarction: the FINAMI Study. Diabetologia 2005; 48:2519-2524.
18. Ulrich P, Cerami A: Protein glycation, diabetes, and aging. Recent Prog Horm Res 2001; 56:1-21.
19. Sims TJ, Rasmussen LM, Oxlund H, Bailey AJ: The role of glycation cross-links in diabetic vascular stiffening. Diabetologia 1996; 39:946-951.
20. Schalkwijk CG, Baidoshvili A, Stehouwer CD, van Hinsbergh VW, Niessen HW. Increased accumulation of the glycoxidation product Nepsilon-(carboxymethyl) lysine in hearts of diabetic patients: generation and characterisation of a monoclonal anti-CML antibody. Biochim Biophys Acta 2004; 1636:82-89.
21. Bucala R, Cerami A: Diabetes; in Gotto AM, Jr, Lenfant C, Catapano AL, Padetti R (eds): Multiple Risk Factors in Cardiovascular Disease: Vascular and Organ Protection. Dordrecht, Kluwer Academic Publishers, 1995, pp 155-163.
22. Makita Z, Radoff S, Rayfield EJ, Yang Z, Skolnik E, Delaney V, et al: Advanced glyco-sylation end products in patients with diabetic nephropathy. N Engl J Med 1991; 325:836-842.
23. Kawaguchi M, Techigawara M, Ishihata T, Asakura T, Saito F, Maehara K, et al: A comparison of ultrastructural changes on endo-myocardial biopsy specimens obtained from patients with diabetes mellitus with and without hypertension. Heart Vessels 1997; 12:267-274.
24. Becker AE, Anderson RH: Cardiac Pathology. An Integrated Text and Colour Atlas. Edinburgh, Churchill Livingstone, 1983, p 17.
25. Vermeulen EG, Niessen HW, Bogels M, Ste-houwer CD, Rauwerda JA, van Hinsbergh VW: Decreased smooth muscle cell/extracellular matrix ratio of media of femoral artery in patients with atherosclerosis and hy-perhomocysteinemia. Arterioscler Thromb Vasc Biol 2001; 21:573-577.
26. Lendon CL, Davies MJ, Born GV, Richardson PD: Atherosclerotic plaque caps are locally weakened when macrophages density is increased. Atherosclerosis 1991; 87:87-90.
27. Pallant J: SPSS Survival Manual. A step by step guide to data analysis using SPSS for windows (version 12), ed 2. Maidenhead, Open University Press, 2005, pp 121-127.
28. Fischer VW, Barner HB, Leskiw ML: Capillary basal laminar thickness in diabetic human myocardium. Diabetes 1979; 28:713-719.
29. Kilo C, Vogler N, Williamson JR: Muscle capillary basement membrane changes related to aging and to diabetes mellitus. Diabetes 1972; 21:881-905.
30. Fluckiger W, Perrin I V, Rossi GL: Morpho-metric studies on retinal microangiopathy and myocardiopathy in hypertensive rats (SHR) with induced diabetes. Virchows Arch B Cell Pathol Incl Mol Pathol 1984; 47:79-94.
31. Kuiper EJ, Hughes JM, Van Geest RJ, Vogels IM, Goldschmeding R, Van Noorden CJ, et al: Effect of VEGF-A on expression of profi-brotic growth factor and extracellular matrix genes in the retina. Invest Ophthalmol Vis Sci 2007; 48:4267-4276.
32. Bruneval P, Foidart JM, Nochy D, Camilleri JP, Bariety J: Glomerular matrix proteins in nodular glomerulosclerosis in association with light chain deposition disease and diabetes mellitus. Hum Pathol 1985; 16:477-484.
33. Scheinman JI, Steffes MW, Brown DM, Mau-er SM: The immunohistopathology of glo-merular antigens. III. Increased mesangial actomyosin in experimental diabetes in the rat. Diabetes 1978; 27:632-637.
34. Sharma K, Ziyadeh FN: Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes 1995; 44:1139-1146.
35. MacKay K, Striker LJ, Stauffer JW, Doi T, Agodoa LY, Striker GE: Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest 1989; 83:1160-1167.
36. Nakamura T, Miller D, Ruoslahti E, Border WA: Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-beta 1. Kidney Int 1992; 41:1213-1221.
37. Suzuki S, Ebihara I, Tomino Y, Koide H: Transcriptional activation of matrix genes by transforming growth factor beta 1 in me-sangial cells. Exp Nephrol 1993; 1:229-237.